TREATMENT OF PLASMA-CELL MYELOMA WITH PREDNISONE (P) AND SEQUENTIAL, ALTERNATING, OR CONCURRENT SCHEDULES OF MELPHALAN (M), CYCLOPHOSPHAMIDE (CTX) AND CARMUSTINE (BCNU)

被引：0
|
作者：
BERGSAGEL, DE [1 ]
BAILEY, AJ [1 ]
LANGLEY, GR [1 ]
MACDONALD, N [1 ]
WHITE, DF [1 ]
MILLER, AB [1 ]
机构：
[1] NATL CANC INST CANADA,TORONTO M5S 2R9,ONTARIO,CANADA
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1977年 / 18卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：329 / 329
页数：1
相关论文
共 19 条
  • [1] MULTIPLE-MYELOMA RESISTANT TO MELPHALAN - TREATMENT WITH DOXORUBICIN, CYCLOPHOSPHAMIDE, CARMUSTINE (BCNU), AND PREDNISONE
    KYLE, RA
    PAJAK, TF
    HENDERSON, ES
    NAWABI, IU
    BRUNNER, K
    HENRY, PH
    MCINTYRE, OR
    HOLLAND, JF
    [J]. CANCER TREATMENT REPORTS, 1982, 66 (03): : 451 - 456
  • [2] PHASE-III STUDY OF INTERMITTENT CARMUSTINE (BCNU), CYCLOPHOSPHAMIDE, AND PREDNISONE VERSUS INTERMITTENT MELPHALAN AND PREDNISONE IN MYELOMA
    ABRAMSON, N
    LURIE, P
    MIETLOWSKI, WL
    SCHILLING, A
    BENNETT, JM
    HORTON, J
    [J]. CANCER TREATMENT REPORTS, 1982, 66 (06): : 1273 - 1277
  • [3] COMBINATION CHEMOTHERAPY FOR MULTIPLE-MYELOMA WITH MELPHALAN, PREDNISONE, CYCLOPHOSPHAMIDE, VINCRISTINE, AND CARMUSTINE (BCNU) (M-2 PROTOCOL)
    TIRELLI, U
    CRIVELLARI, D
    CARBONE, A
    VERONESI, A
    GALLIGIONI, E
    TROVO, MG
    TUMOLO, S
    GRIGOLETTO, E
    [J]. CANCER TREATMENT REPORTS, 1982, 66 (11): : 1971 - 1973
  • [4] MULTIPLE-MYELOMA RESISTANT TO MELPHALAN - TREATMENT WITH CYCLOPHOSPHAMIDE, PREDNISONE, AND BCNU
    KYLE, RA
    GAILANI, S
    SELIGMAN, BR
    BLOM, J
    MCINTYRE, OR
    PAJAK, TF
    HOLLAND, JF
    [J]. CANCER TREATMENT REPORTS, 1979, 63 (08): : 1265 - 1269
  • [5] A prospective randomized trial of melphalan and prednisone versus vincristine Carmustine (BCNU), melphalan, cyclophosphamide, and prednisone in the treatment of primary systemic amyloidosis.
    Gertz, MA
    Lacy, MQ
    Lust, JA
    Greipp, PR
    Witzig, TE
    Kyle, RA
    [J]. BLOOD, 1998, 92 (10) : 318A - 319A
  • [6] MELPHALAN PREDNISONE VERSUS DRUG-COMBINATIONS FOR PLASMA-CELL MYELOMA
    BERGSAGEL, DE
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 1989, 43 : 117 - 123
  • [7] MELPHALAN PREDNISONE VERSUS DRUG-COMBINATIONS FOR PLASMA-CELL MYELOMA
    BERGSAGEL, DE
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, SUPPL NO 51, VOL 43, 1989: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON MULTIPLE MYELOMA - BIOLOGY, PATHOPHYSIOLOGY, PROGNOSIS AND TREATMENT, 1989, : 117 - 123
  • [8] The Treatment of Multiple Myeloma Using Vincristine, Carmustine, Melphalan, Cyclophosphamide, and Prednisone (VBMCP) Alternating With High-dose Cyclophosphamide and α2β Interferon Versus VBMCP
    Kyle, Robert A.
    Jacobus, Susanna
    Friedenberg, William R.
    Slabber, Coenraad Frederik
    Rajkumar, S. Vincent
    Greipp, Philip R.
    [J]. CANCER, 2009, 115 (10) : 2155 - 2164
  • [9] TREATMENT OF ADVANCED PLASMA-CELL MYELOMA WITH WEEKLY CYCLOPHOSPHAMIDE AND ALTERNATE-DAY PREDNISONE
    BRANDES, LJ
    ISRAELS, LG
    [J]. CANCER TREATMENT REPORTS, 1982, 66 (06): : 1413 - 1415
  • [10] EFFECTIVENESS OF 2-STAGE TREATMENT OF MULTIPLE-MYELOMA WITH MELPHALAN AND WITH MELPHALAN IN COMBINATION WITH CYCLOPHOSPHAMIDE, CARMUSTINE, VINCRISTINE AND PREDNISONE
    SNIGUROWICZ, J
    KRAJ, M
    ROSTKOWSKA, J
    MAJ, S
    MARIANSKA, B
    MENDEK, E
    ROSZKOWSKI, S
    KILIAN, Z
    KOLAKOWSKI, L
    [J]. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 1981, 29 (02) : 145 - 153
12